Residual Stenosis and Restenosis Following Carotid Endarterectomy With Primary Closure, A Prospective Tracking Study
RECEPT
1 other identifier
observational
300
1 country
1
Brief Summary
This prospective, multicenter observational study aims to evaluate the incidence, timing, and characteristics of residual and recurrent (restenosis) carotid artery stenosis following carotid endarterectomy (CEA) with primary closure. Conducted across several neurosurgical centers in the Czech Republic, the study will include patients undergoing elective CEA who meet standard clinical indications. Participants will undergo preoperative CT angiography and follow-up imaging at 30 days and 1 year post-surgery. Residual stenosis is defined as ≥50% luminal narrowing detected within 30 days postoperatively, while restenosis is evaluated at later time points. The study will also assess clinical outcomes such as ischemic stroke, TIA, myocardial infarction, and mortality. The standardized surgical technique and harmonized diagnostic algorithm across all centers aim to provide robust data on the performance and durability of primary closure CEA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2025
CompletedFirst Submitted
Initial submission to the registry
June 30, 2025
CompletedFirst Posted
Study publicly available on registry
July 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
ExpectedJuly 9, 2025
June 1, 2025
11 months
June 30, 2025
June 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Restenosis ≥50% at 12 months
Restenosis ≥50% at 12 months
12 months
Secondary Outcomes (3)
Restenosis ≥50%
30 days
iCMP/TIA/death/MI
1 year
Change in modified Rankin Scale (mRS)
1 year
Study Arms (1)
Patients after carotid endarterectomy
Included paitnets with sign informed consent after carotid endarterectomy
Eligibility Criteria
Patients who undergo carotid endarterectomy for carotid artery stenosis with primary suture.
You may not qualify if:
- Age ≤18 or ≥90 years
- Previous endarterectomy or stenting
- Unsuitable vascular anatomy
- High perioperative risk
- Contralateral cranial nerve X or XII palsy
- History of neck irradiation
- Tandem carotid stenosis or intracranial vascular pathology (e.g., aneurysm or AVM)
- Absence of signed informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Charles University, Czech Republiclead
- The University Hospital Plzeňcollaborator
- Masaryk Hospital Usti nad Labemcollaborator
- University Hospital Olomouccollaborator
- County Hospital Liberec, Liberec, Czech Republiccollaborator
Study Sites (1)
Central Military Hospital Prague
Prague, 16200, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- cpt. MD. Norbert Svoboda, PhD., FEBNS
Study Record Dates
First Submitted
June 30, 2025
First Posted
July 9, 2025
Study Start
February 1, 2025
Primary Completion
January 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
July 9, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- 2/2027 - 2/2028
- Access Criteria
- online
Epidemiologic risk factors: age, sex, diabetes, hypertension, dyslipidemia, metabolic syndrome, renal insufficiency, smoking, physical activity, weight, comorbidities Laboratory markers: LDL, HDL, cholesterol, lipoprotein A, triglycerides, CKD-EPI, sedimentation rate, fibrinogen, INR (Quick test), APTT